Literature DB >> 8604734

Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

J W Harbour1, W E Smiddy, H W Flynn, P E Rubsamen.   

Abstract

PURPOSE: To evaluate the surgical results in a series of patients with diabetic macular edema associated with traction from a thickened and taut posterior hyaloid membrane and to identify features associated with better visual outcome.
METHODS: We reviewed the clinical records of ten consecutive patients who underwent pars plana vitrectomy in one eye for diabetic macular edema that was preoperatively attributed to thickening and traction of the posterior hyaloid membrane.
RESULTS: Best-corrected, preoperative visual acuity was 20/200 in seven eyes, 20/300 in one eye, and 20/400 in two eyes. Intraoperatively, seven patients were found to have an attached posterior hyaloid membrane which was thickened and taut. Among these seven patients, postoperative best-corrected visual acuity improved by six lines in two eyes, by five lines in one eye, by two lines in one eye, and remained within one line of preoperative visual acuity in three eyes. The other three patients had an epiretinal membrane simulating an attached and thickened posterior hyaloid membrane.
CONCLUSIONS: Vitrectomy effectively improved visual acuity in some eyes with diabetic macular edema associated with traction from a thickened and taut posterior hyaloid membrane. Despite careful preoperative examination with a fundus contact lens, however, in some patients it may be difficult to assess how the posterior hyaloid membrane contributes to the macular edema. In selected patients, early surgical intervention may be associated with better visual outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8604734     DOI: 10.1016/s0002-9394(14)70437-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  74 in total

1.  Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.

Authors:  A Gandorfer; E Putz; U Welge-Lüssen; M Grüterich; M Ulbig; A Kampik
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Effects of haemodialysis on diabetic macular leakage.

Authors:  T Tokuyama; T Ikeda; K Sato
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

3.  Epiretinal pathology of vitreomacular traction syndrome.

Authors:  A Gandorfer; M Rohleder; A Kampik
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

4.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

Review 5.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

6.  Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).

Authors:  David J Browning
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

7.  Morphological and functional changes of the macula after vitrectomy and creation of posterior vitreous detachment in eyes with diabetic macular edema.

Authors:  Shuichi Yamamoto; Teiko Yamamoto; Kazuha Ogata; Akiko Hoshino; Eiju Sato; Satoshi Mizunoya
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

8.  Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration.

Authors:  A Weber; A E Elsner; M Miura; S Kompa; M C Cheney
Journal:  Eye (Lond)       Date:  2006-01-06       Impact factor: 3.775

9.  Perifoveal vitreous detachment and its macular complications.

Authors:  Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

10.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Authors: 
Journal:  Ophthalmology       Date:  2008-07-26       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.